| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 7.29▲ | 7.31▼ | 7.30▲ | 7.34▼ | 7.56▼ |
| MA10 | 7.31▼ | 7.30▲ | 7.31▼ | 7.52▼ | 7.56▼ |
| MA20 | 7.31▼ | 7.33▼ | 7.36▼ | 7.71▼ | 7.97▼ |
| MA50 | 7.31▼ | 7.38▼ | 7.46▼ | 7.58▼ | 9.86▼ |
| MA100 | 7.37▼ | 7.53▼ | 7.69▼ | 8.15▼ | N/A |
| MA200 | 7.44▼ | 7.71▼ | 7.78▼ | 9.27▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.003▼ | 0.004▲ | 0.003▲ | -0.069▼ | 0.105▲ |
| RSI | 49.767▼ | 45.889▼ | 43.829▼ | 43.920▼ | 42.869▼ |
| STOCH | 12.957▼ | 53.826 | 55.263 | 18.125▼ | 58.407 |
| WILL %R | -70.588 | -36.842 | -52.000 | -87.543▼ | -64.168 |
| CCI | -52.496 | 7.170 | -30.266 | -115.659▼ | -68.057 |
| CDL | $GYRE Doji Candlestick Pattern Detected | Set Alert |
|
Friday, September 05, 2025 09:05 AM
SAN DIEGO, Sept. 05, 2025 (GLOBE NEWSWIRE) -- Gyre Therapeutics (“Gyre”) (Nasdaq: GYRE), an innovative, commercial-stage biopharmaceutical company dedicated to advancing fibrosis-first therapies ...
|
|
Wednesday, August 27, 2025 05:05 PM
H.C. Wainwright initiated coverage of Gyre Therapeutics (GYRE) with a Buy rating and $18 price target The company’s lead asset hydronidone is a structural analog of the anti-fibrotic drug pirfenidone ...
|
|
Tuesday, August 26, 2025 07:52 AM
The global biopharmaceutical landscape is rapidly evolving, driven by innovations targeting complex diseases like organ fibrosis and liver conditions. As companies push the boundaries of medical ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/09/25 | 7.31 | 7.37 | 7.13 | 7.29 | 45,770 |
| 24/09/25 | 7.3432 | 7.44 | 7.28 | 7.37 | 29,854 |
| 23/09/25 | 7.42 | 7.545 | 7.28 | 7.30 | 45,302 |
| 22/09/25 | 7.26 | 7.5505 | 7.2106 | 7.47 | 62,673 |
| 19/09/25 | 7.71 | 7.71 | 7.11 | 7.25 | 442,210 |
| 18/09/25 | 7.60 | 7.74 | 7.49 | 7.69 | 61,200 |
| 17/09/25 | 7.59 | 7.87 | 7.51 | 7.54 | 57,824 |
| 16/09/25 | 7.88 | 7.90 | 7.55 | 7.59 | 54,312 |
| 15/09/25 | 7.82 | 8.01 | 7.6666 | 7.90 | 55,623 |
| 12/09/25 | 8.15 | 8.28 | 7.80 | 7.83 | 75,000 |
|
|
||||
|
|
||||
|
|